A full list of publications can be found here.
Publications indexed in Pubmed are here.
Feel free to email me to obtain a copy of any of the papers below.
Peer-reviewed papers
Submitted
[110] Kouassi AK, Simo Fotso A, Rouveau N,
Maheu-Giroux M, Boily MC, Silhol R, d’Elbée M, Vautier
A, Larmarange J, on behalf of the ATLAS team (2023). HIV self-testing
positivity rate and linkage to confirmatory testing and care: a
telephone survey in Côte d’Ivoire, Mali, and Senegal. Pre-print here.
[109] Milwid RM, Li M, Fazil A, Maheu-Giroux
M, Doyle CM, Xia Y, Cox J, Grace D, Dvorakova M, Walker SC,
Mishra SM, Ogden NH (2023). Exploring the dynamics of the 20222 mpox
outbreak in Canada.
[108] Sardinha L, Stöckl H, Maheu-Giroux
M, Meyer SR, García-Moreno C (2023). A persistent pandemic: the
global prevalence of sexual violence against women.
[107] Silhol R, Maheu-Giroux M,
Soni N, Simo Fotso A, Rouveau N, Vautier A, Doumenc-Aidara C, Geoffroy
O, N’Guessan KN, Sidibe Y, Kabemba OK, Gueye PA, Mukandavire C,
Vickerman P, Keita A, Ndour CT, Ehui E, Larmarange J, Boily MC, The
ATLAS Team (2023). Assessing the potential population-level impacts of
HIV self-testing distribution among key populations in Côte d’Ivoire,
Mali, and Senegal: a mathematical modelling analysis. Pre-print here.
[106] Xiu F+, Flores Anato JL+ (+contributed
equally), Cox J, Grace D, Hart TA, Skakoon-Sparling S, Dvorakova M,
Knight J, Wang L, Gatalo, O, Campbell E, Zhang T, Sbihi H, Irvine MA,
Mishra S, Maheu-Giroux M (2023). Characteristics of the
sexual networks of gay, bisexual, and other men who have sex with men in
Montréal, Toronto, and Vancouver: implications for the transmission and
control of mpox in Canada. Pre-print here.
[105] Steven O, Anderson R, Stover J, Teng Y,
Stannah J, Silhol R, Jones H, Booton RD, Martin-Hughes R, Johnson LF,
Maheu-Giroux M, Mishra S, Stone J, Bershteyn A, Sabin
K, Mitchell KM, Dimitrov D, Baral S, Donnell D, Korenromp E, Rice B,
Hargreaves J, Vickerman P, Mahy M, Boily MC, Eaton JW (2023). Comparison
of empirical and model-based key population HIV incidence and the
distribution of new infections by population groups in sub-Saharan
Africa.
[104] Silhol R, Anderson RL, Stevens O, Stannah J,
Booton RD, Baral S, Dimitrov D, Mitchell K, Donnell D, Bershteyn, Brown
T, Kelly SL, Kim HY, Johnson LF, Maheu-Giroux M,
Martin-Hugues R, Mishra S, Peerapatanapokin W, Stone J, Stover J, Stuart
R, Teng Y, Vickerman P, Wilson DP, Korenromp E, Eaton JW, Boily MC
(2023). Fractions of HIV infections acquired by non-key populations
partners of key population: estimates from HIV transmission-dynamic
models.
[103] Juwono S, Flores Anatao JL, Kirschbaum A,
Metheny N, Dvorakova M, Skakoon-Sparling S, Moore DM, Grace D, Hart TA,
Lambert G, Lawchosky NJ, Jollimore J, Cox J, Maheu-Giroux
M (2023). Prevalence, determinants, and trends in the
experience and perpetration of intimate partner violence among a cohort
of gay, bisexual, and other men who have sex with men in Montréal,
Toronto, and Vancouver, Canada (2017-2022). Pre-print here.
[102] Stevens O, Anderson R, Sabin K, Arias Garcia
S, Fearon E, Manda K, Dikobe W, Crowell TA, Tally L, Mulenga L, Neena P,
Maheu-Giroux M, McIntyre A, Hladik W, Zhao J, Mahy M,
Eaton JW (2023). HIV prevalence in transgender populations and cisgender
men who have sex with men in sub-Saharan Africa 2010-2022: a
meta-analysis.
[101] Doyle CM, Milwid RM, Cox J, Xia Y, Lambert G,
Tremblay C, Otis J, Boily MC, Baril JG, Mercure SA, Thomas R, Trottier
B, Mishra S, Maheu-Giroux M (2023). Population-level
impact of pre-exposure prophylaxis on HIV acquisitions among men who
have sex with men: a mathematical modeling study in Montréal, Canada
(2013-2021). Pre-print here.
[100] Xia Y, Flores Anato JL, Colijin C, Janjua N,
Otterstatter M, Irvine N, Tyler Williamson, Varughese MB, Li M, Osgood
N, Earn DJD, Sander B, Cipriano LE, Murthy K, Xiu F, Godin G, Buckeridge
DL, Hurford H, Sharmistha Mishra S, and Maheu-Giroux M
(2023). Canada’s provincial COVID-19 pandemic modelling efforts: a
review of mathematical models and their impacts on the responses.
Pre-print here.
[99] Yokoji K, Giguère K (co-first authors), Rönn
MM, Dalal S, Mayaud P, Kelly H, Delany-Moretlwe S, Drolet M, Brisson M,
Boily MC, Maheu-Giroux M (2023). Association of
naturally acquired type-specific HPV antibodies and subsequent HPV
re-detection: Systematic review and meta-analysis.
[98] Boye S, Kouadio A, Kouvahe AF, Vautier A,
Ky-Zerbo O, Rouveau N, Maheu-Giroux M, Larmarange J,
Pourette D, and the ATLAS Team (2023). Organisation of testing services,
barriers and facilitators to routine HIV self-testing during sexually
transmitted infection consultations: a qualitative study of patients and
providers in Abidjan, Côte d’Ivoire.
[97] Eaton JW, Sands A, Barr-DiChiara M, Jamil M,
Baggaley R, Tippet Barr BA, Kalua T, Jahn A, Maheu-Giroux
M, Johnson CC (2023). Accuracy and performance of the WHO 2015
and WHO 2019 HIV testing strategies across epidemic settings. (preprint
here)
Published
[96]
Kouassi Kra A, Simo Fosto A, N’guessan KN, Geoffroy O, Younoussa S,
Kabemba OK, Gueye PA, Ndeye PD, Rouveau N, Maheu-Giroux
M, Boily MC, Silhol R, d’Elbée M, Vautier A, Larmarange J, and
the ATLAS Team (2023). Can HIV self-testing reach first-time testers? A
telephone survey among self-test end users in Côte d’Ivoire, Mali, and
Senegal. BMC Supplement. (Accepted)
[94] Kuchukhidze S, Panagiotoglou, Boily MC, Diabaté s,
Eaton JW, Stöckl H, Mbofana F, Wanyenze RK, and Maheu-Giroux
M (2023). Characteristics of male perpetrators of intimate
partner violence and implications for women’s HIV status: a pooled
analysis of cohabiting couples from sub-Saharan Africa (2000-2020).
PLOS Global Public Health 3(9):e0002146.
[93] Flores Anato JL, Ma H, Hamilton MA, Xia Y, Harper
S, Buckeridge D, Brisson M, Hillmer MP, Malikov K, Aidin Kerem, Beall R,
Baral S, Dubé È, Mishra S, Maheu-Giroux M (2023).
Impact of a vaccine passport on first-dose vaccine coverage by age and
area-level social determinants of health in the Canadian provinces of
Québec and Ontario: an interrupted time series analysis. CMAJ
Open. (Accepted)
[92] Caya C, Singh AE, Serhir B, Morin V, Libman MD,
Corsini R, Goldfarb DM, Wong T, Xia Y, Maheu-Giroux M,
and Yansouni CP (2023). Rapid diagnostic testing for syphilis in Arctic
communities (the STAR study): A multisite prospective field diagnostic
accuracy study in an intended-use setting. Clinical Microbiology and
Infection. (Accepted)
[91] Silhol R, Nordsletten A, Maheu-Giroux
M, Elmes J, Staunton R, Owen B, Shacklett B, McGowan I, Gomez
Feliciano K, van der Straten A, Eller LA, Robb M, Mararazzo J, Dimitrov
D, Boily MC (2023). The association between heterosexual anal
intercourse and HIV acquisition in three prospective cohorts of women.
AIDS and Behavior. (Accepted)
[90] Stansfield S, Heitner J, Mitchell K, Doyle CM,
Milwid R, Moore J, Donnell D, Hanscom B, Xia Y, Maheu-Giroux
M, Van de Vijver D, Wang H, Barnabas R, Boily MC, Dimitrov D
(2023). Population-level impact of expanding PrEP coverage by offering
long-acting injectable PrEP to MSM in three high resources settings: a
model comparison analysis. Journal of the International AIDS
Society 26(S2):e26109.
[89] Ky-Zerbo O, Desclaux A, Boye S,
Maheu-Giroux M, Rouveau N, Vautier A, Camara CS,
Kouadio BA, Sow S, Gueye PA, Geoffroy O, Kamemba OK, Ehui E, Ndour CT,
Keita A, Larmarange J, and the ATLAS Team (2023). “I take it and give it
to my partners who will give it to their partners”: Secondary
distribution of HIV self-tests (HIVST) by key populations in Côte
d’Ivoire, Mali, and Senegal. BMC Infectious Diseases 22:970.
[88] Stannah J, Soni R, Lam JKS, Giguère K, Mitchell K,
Kronfli N, Larmarange J, Moh R, N’zebo Nouaman M, Kouamé GM, Boily MC,
Maheu-Giroux M (2023). Trends in HIV testing, the
treatment cascade, and HIV incidence among men who have sex with men in
Africa: A systematic review and meta-analysis. The Lancet HIV
10(8):e528-e542.
[86] Yang L, Boily MC, Rönn MM, Obiri-Yeboah D,
Morhason-Bello I, Meda N, Lompo Olga, Mayaud P, Pickles M, Hodgins C,
Brisson M, Delany-Moretlwe S, Maheu-Giroux M (2023).
Regional and country-level trends in cervical cancer screening coverage
in sub-Saharan Africa: a systematic analysis of population-based surveys
(2000-2020). PLoS Medicine 20(1):e1004143.
[85] Kuchukhidze S, Panagiotoglou D, Boily MC, Diabaté
S, Eaton JW, Mbofana F, Sardinha L, Schrubbe L, Stöckl H, Wanyenze R,
and Maheu-Giroux M (2023). The effects of intimate
partner violence on women’s risk of HIV acquisition and engagement in
the HIV treatment and care cascade: a pooled analysis of nationally
representative surveys in sub-Saharan Africa. The Lancet HIV
10(2):E107-E117.
[81] Staagdegaard L, Soni N, Bellerose M, Dala S, Bloem
P, Brisson M, Maheu-Giroux M, Barnabas R, Drolet M,
Mayaud P, Rönn MM, Boily MC (2022). Immunogenicity, safety, and efficacy
of the HPV vaccines in people living with HIV: a systematic review and
meta-analysis. eClinical Medicine 52:101585.
[80] Simo Fotso A, Johnson C, Vautier A, Kouamé KB,
Diop PM, Silhol R, Maheu-Giroux M, Boily MC, Rouveau N,
Doumenc-Aïdara S, Baggaley R, Ehui E, Larmarange J, and the ATLAS
Team (2022). Routine programmatic data show a positive
population-level impact of HIV self-testing: the case of Côte d’Ivoire
and implications for implementation. AIDS 36(13):1871-1879.
[79] Owen BN, Baggaley RF, Maheu-Giroux
M, Elmes J, Adimora AA, Ramirez C, Edmonds A, Sosanya K, Taylor
TT, Plankey M, Cederbaum JA, Seidman D, Weber KM, Golub ET, Wells J,
Bolivar H, Konkle-Parker D, Pregartner G, Boily MC (2022). Longitudinal
determinants of anal intercourse among women with, and without HIV in
the United States. BMC Women’s Health 22:291.
[78] Traore MM, Badiane (co-first author), Vautier A,
Fotso AS, Kabemba OK, Rouveau N, Maheu-Giroux M, Boily
MC, Larmarange J, Terris-Prestholt F, d’Elbée M, and the ATLAS Team
(2022). Economic analysis of low volume interventions using real-world
data: Costs of HIV self-testing distribution and HIV testing services in
west Africa from the ATLAS project. Frontiers in Health
Services 2:886513.
[76] Xia Y, Ma H, Buckeridge DL, Brisson M, Sander B,
Chan A, Verma A, Ganser I, Kronfli N, Mishra S, Maheu-Giroux
M (2022). Mortality trends and length of stays among
hospitalized COVID-19 patients in Ontario and Québec (Canada): a cohort
study of the first three epidemic waves. The International Journal
of Infectious Diseases 121:1-10.
[75] Ky-Zerbo O, Desclaux A, Boye S, Vautier A, Rouveau
N, Kouadio Brou A, Fotso Arlette S, Pourette D, Maheu-Giroux
M, Sow S, Camara CS, Clémence DA, Keita A, Boily MC, Silhol R,
D’elbée M, Bekelynck A, Gueye Papa A, Diop Papa M, Geoffroy O, Kamemba
Odé K, Diallo S, Ehui E, Ndour Cheick T, and Larmarange J for the
ATLAS Team (2022). Willingness to use and distribute HIV
self-test kits to clients and partners: a qualitative analysis of female
sex workers’ collective opinion and attitude in Côte d’Ivoire, Mali, and
Senegal. Women’s Health 18:1-11.
[74] Milwid R, Xia Y, Doyle C, Cox J, Lambert G, Thomas
R, Mishra S, Grace D, Lachowsky NJ, Hart TA, Boily MC, and
Maheu-Giroux M (2022). Past dynamics of HIV
transmission among men who have sex with men in Montréal, Canada: a
mathematical modeling study. BMC Infectious Diseases 22:233.
[72] Lanièce Delaunay C, Maheu-Giroux
M, Marathe G, Saeed S, Martel-Laferrière, Cooper CL, Walmsey S,
Cox J, Wong A, and Klein MB, for the Canadian Coinfection Cohort
Investigators (2022). Gaps in hepatitis C virus prevention and care
for HIV-hepatitis C virus co-infected people who injected drugs in
Canada. International Journal of Drug Policy 103:1-10.
[71] Kronfli N, Dussault C, Maheu-Giroux
M, Halavrezos A, Chalifoux S, Sherman J, Park H, Del Balso L,
Cheng MP, Poulin S, Cox J (2022). Seroprevalence and risk factors for
SARS-CoV-2 among incarcerated adult men in Quebec, Canada (2021): a
cross-sectional study. Clinical Infectious Diseases. (Accepted)
[70] Xia Y, Ma H, Moloney G, Velásquez García HA,
Sirski M, Janjua NZ, Vickers D, Williamson T, Katz A, Yu K, Kustra R,
Buckeridge DL, Brisson M, Baral SD, Mishra S, and Maheu-Giroux
M (2022). Geographical concentration of SARS-CoV-2 cases by
social determinants of health in metropolitan areas in Canada: a
cross-sectional study. Canadian Medical Association Journal
194(6):E195-E204.
[69] Simo Fosto A, Kouassi Kra A, Maheu-Giroux
M, Boye S, d’Elbée M, Ky-Zerbo O, Rouveau N, N’Guessan NK,
Geoffroy O, Vautier A, Larmarange, the ATLAS Team (2022). Is it
possible to recruit HIV self-test users for an anonymous phone-based
survey using passive recruitment without financial incentives? Lessons
learned from a pilot study in Côte d’Ivoire. Pilot and Feasibility
Studies 8:4.
[68] Sardinha L, Maheu-Giroux M,
Stöckl H, Meyer S, García-Moreno C (2022). Global, regional, and
national prevalence of intimate partner violence against women (2018).
The Lancet 399(10327):803-813.
[67] Flores Anato JL, Panagiotoglou D, Greenwald ZR,
Blanchette M, Trottier C, Vaziri M, Charest L, Szabo J, Thomas R, and
Maheu-Giroux M (2022). Chemsex and incidence of
sexually transmitted infections among Canadian pre-exposure prophylaxis
(PrEP) users in the l’Actuel PrEP Cohort (2013-2020). Sexually
Transmitted Infections 0:1-8.
[66] Hodgins C, Stannah J, Kuchukhidze S, Lycias Z,
Eaton JW, Boily MC, Maheu-Giroux M (2022). Population
sizes, HIV prevalence, and HIV prevention among men who paid for sex in
sub-Saharan Africa: a meta-analysis of 87 population-based surveys
(2000-2020). PLOS Medicine 19(1):e1003861.
[65] Panagiotoglou D, Abrahamowicz M, Buckeridge D,
Caro JJ, de Montigny L, Latimer EA, Maheu-Giroux M, and
Strumpf EC (2021). Evaluating Montréal’s harm reduction interventions
for people who inject drugs: protocol for observational study and
cost-effectiveness analysis. BMJ Open 11(10):e053191.
[64] Giguère K, Vaziri M, Olivier C, Charest L, Szabo
J, Thomas R, Maheu-Giroux M (2021). Characteristics of
new HIV diagnoses over 1983-2019: a clinic-based study in Montréal
(Canada). PLOS One 16(10):e0258383.
[63] Mitchell KM, Maheu-Giroux M,
Dimitrov D, Moor M, Hughes JP, Donnel D, Beyrer C, El-Sadr W, Cohen MS,
Boily MC (2021). How can progress toward Ending the HIV Epidemic in the
United States be monitored? Clinical Infectious Diseases
75(1):163-169.
[62] Ky-Zerbo O, Desclaux A, Brou Kouadio A, Rouveau R,
Vautier A, Sow S, Sidi Camara C, Boye S, Pourette D, Sidibe Y,
Maheu-Giroux M, Larmarange J, and the ATLAS
Team (2021). Enthusiasm for introducing and integrating HIV
self-testing but doubts about users: a baseline qualitative analysis of
key stakeholders’ attitudes and perceptions in Côte d’Ivoire, Senegal,
and Mali. Frontiers in Public Health 9:1525.
[61] Maheu-Giroux M, Ciaranello AL,
Salomon JA, Sohn AH (2021). Refining global HIV estimates for
decision-making: advances in analytic and modeling methods used by the
Joint United Nations Programme on HIV/AIDS. Journal of the
International AIDS Society 24(S5):e25790.
[60] Mishra S, Ma H, Moloney G, Yiu KCY, Darvin D,
Landsman D, Kwong JC, Calzavara A, Straus S, Chan AK, Gournis E, Rilkoff
H, Xia Y, Katz A, Williamson T, Malikov K, Kustra R,
Maheu-Giroux M, Sander B, Baral SD, and the COVID-19
Heterogeneity Research Group (2021). Increasing concentration of
COVID-19 by socioeconomic determinants and geography in Toronto, Canada:
an observational study. Annals of Epidemiology 65:84-92.
[54] d’Elbée M, Traore MM, Badiane K, Vautier A, Simo
Fosto A, Kabemba OK, Rouveau N, Godfrey-Faussett P, Maheu-Giroux
M, Boily MC, Medley G, Larmarange J, Terris-Prestholt F, and
the ATLAS Team (2021). Preparing for sustainable scale-up:
economic analysis of HIV self-testing kits provision by civil society
organizations to key populations and their sexual partners in Côte
d’Ivoire, Senegal, and Mali. Frontiers in Public Health
(Accepted).
[53] Boye S, Bouaré S, Ky-Zerbo O, Rouveau N, Simo
Fotso A, d’Elbée M, Silhol S, Maheu-Giroux M, Vautier
A, Breton G, Keita A, Bekelynck A, Desclaux A, Larmarange J, Pourette D,
and the ATLAS Team (2021). Challenges of HIV self-test
distribution for index testing when HIV status disclosure is low: an
ethnographic study in Bamako (Mali) as part of the ATLAS project.
Frontiers in Public Health. Frontiers in Public Health
(Accepted).
[51] Silhol R, Geidelberg L, Mitchell KM, Mishra S,
Dimitrov D, Bowring A, Béhanzin L, Guédou F, Diabaté S, Schwartz S,
Billong SC, Njindam IM, Levitt D, Mukandavire C, Maheu-Giroux
M, Rönn MM, Dalal S, Vickerman P, Baral S, Alary M, Boily MC
(2021). Assessing the potential impact of disruptions due to COVID-19 on
HIV among key and lower-risk populations in the largest cities of
Cameroon and Benin. JAIDS – Journal of Acquired Immune Deficiency
Syndrome 87(3):899-911.
[50] Cox J, Apelian H, Moodie EEM, Messier-Peet M, Hart
TA, Grace D, Moore DM, Lachowsky NJ, Armstrong HL, Jollimore J,
Skakoon-Sparling S, Rodrigues R, Tan DHS, Maheu-Giroux
M, Noor SW, Lebouché B, Tremblay C, Olarewaju G, Lambert G, and
the Engage Study Team (2021). HIV pre-exposure prophylaxis (PrEP) use
among urban Canadian gay, bisexual and other men who have sex with men
for whom PrEP is clinically recommended: baseline results from the
Engage Cohort Study. CMAJ Open 9(2):E529-E538.
[49] Rouveau N, Ky-Zerbo O, Boye S, Simo Fotso A,
d’Elbée M, Maheu-Giroux M, Silhol R, Kra Kouassi A,
Vautier A, Doumenc-Aïdara C, Breton G, Keita A, Ehui E, Cheikh Tidiane
N, Boily MC, Terris-Prestholt F, Pourette D, Desclaux A, Larmarange J,
the ATLAS Team (2021). Describing, analysing and understanding
the effects of the introduction of HIV self-testing in West Africa
through the ATLAS programme in Côte d’Ivoire, Mali and Senegal. BMC
Public Health 21:181.
[47] Giguère K, Eaton JW, Marsh K, Johnson LF, Johnson
CC, Ehui E, Jahn A, Wanyeky I, Mbofana F, Bakiono F, Mahy M,
Maheu-Giroux M (2021). Trends in knowledge of HIV
status and efficiency of HIV testing services in sub-Saharan Africa
(2000-2020): a modelling study of survey and HIV testing program data.
The Lancet HIV 8(5):e284-293.
[45] Godin A+, Xia Y+ (+ co-first author), Buckeridge
D, Mishra S, Douwes-Schultz D, Shen Y, Lavigne M, Drolet M, Schmidt A,
Brisson M, and Maheu-Giroux M (2021). The role of case
importation in explaining differences in early SARS-CoV-2 transmission
dynamics in Canada - a mathematical modeling study of surveillance data.
The International Journal of Infectious Diseases 102:254-259.
[43] Xia Y, Greenwald Z, Milwid R, Trottier C,
Boissonnault M, Gaul N, Charest L, Landry G, Szabo J, Thomas R,
Maheu-Giroux M (2020). Pre-exposure prophylaxis uptake
among men who have sex with men who used non-occupational post-exposure
prophylaxis: a longitudinal analysis of attendees at a large sexual
health clinic in Montréal (Canada). JAIDS Journal of Acquired Immune
Deficiency Syndromes 85(4):408-415.
[42] Doyle C, Maheu-Giroux M, Lambert
G, Mishra S, Apelian H, Messier-Peet M, Otis J, Grace D, Hart TA, Moore
DM, Lachowsky NJ, Cox J, and the Engage Study Team (2020). Combination
HIV prevention among Montreal gay, bisexual, and other men who have sex
with men in the PrEP era: a latent class analysis. AIDS and
Behavior 25:269-283.
[40] Owen BN, Baggaley RF, Maheu-Giroux
M, Elmes J, Adimora A, Ramirez C, Edmonds A, Sosanya K, Taylor
T, Plankey M, Cederbaum J, Seidman D, Weber K, Golub E, Wells J, Bolivar
H, Konkle-Parker D, Boily MC (2020). Patterns and trajectories of anal
intercourse practice over the life course among HIV-negative US women in
the WIHS cohort. The Journal of Sexual Medicine
17(9):1629-1642.
[37] Maheu-Giroux M, Marsh K, Bhatkoti
R, Doyle C, Godin A, Lanièce Delaunay C, Jonhson LF, Jhan A, Abo K,
Mbofana F, Boily MC, Buckeridge DL, Hankins C, and Eaton JW (2019).
National HIV testing and diagnosis coverage in sub-Saharan Africa: a new
modeling tool for estimating the “first 90” from program and survey
data. AIDS 33(Suppl 3):S295-S302.
[36] Maheu-Giroux M, Jahn A, Kalua T,
Mganga A, Eaton JW (2019). HIV surveillance based on routine testing
data from antenatal clinics in Malawi (2011-2018): measuring and
adjusting for bias from imperfect testing coverage. AIDS
33(Suppl 3):S295-S269.
[35] Greenwald ZR, Maheu-Giroux M,
Szabo J, Robin-Bérubé JA, Boissonnault M, Nguyen VK, Thomas R (2019).
Cohort Profile: l’Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study.
BMJ Open 9:e028768.
[34] Maheu-Giroux M and Castro MC
(2019). Attribution of reductions in malaria prevalence in Dar es
Salaam, Tanzania. The Lancet Planetary Health 3(6):e246.
[33] Maheu-Giroux M, Diabaté S, Boily
MC, Jean-Paul N, Vesga JF, Baral S, Abo K, Wogwin V, Diouf D, Alary M
(2019). Cost-effectiveness of accelerated HIV response scenarios in Côte
d’Ivoire. JAIDS Journal of Acquired Immune Deficiency Syndromes
80(5):503-512.
[32] Maheu-Giroux M and Joseph SA
(2018). Moxidectin for deworming: from trials to implementation. The
Lancet Infectious Diseases S1473-3099(18)30270-6.
[29] Maheu-Giroux M, Baral S, Vesga
JF, Diouf D, Diabaté S, Alary M, Abo K, and Boily MC (2017). Anal
intercourse among female sex workers in Côte d’Ivoire: prevalence,
frequency, determinants, and model-based estimates of its
population-level impact on HIV transmission. American Journal of
Epidemiology 187(2):287-197.
[8] Blouin B, Penny ME, Maheu-Giroux
M, Casapía M, Aguilar E, Silva H, Creed-Kanashiro H, Joseph SA,
Gagnon A, Rahme E, and Gyorkos TW (2013). Timing of umbilical cord
clamping and infant anemia: the role of maternal anemia. Paediatrics
& International Child Health 33(2):79-85.
Editorials and book reviews
Reports
Doyle CM, Xia Y, Flores Anato JL, and
Maheu-Giroux M (2023). Evidence review of innovations
in public health surveillance of HIV. Public Health Agency of Canada
(PHAC). Ottawa, ON (48 pages).
Stansfield S, Heitner J, Mitchell K, Doyle CM, Milwid RM,
Maheu-Giroux M, Jamieson L, Meyer-Rath G, Johnson LF,
Smith J, Philips A, Boily MC, Dimitrov D (2022). Projected population
impact of expanding PrEP coverage by offering long-acting injectable
PrEP in different settings: model comparison analysis. In: Guidelines on
Long-Acting Injectable Cabotegravir for HIV Prevention. Geneva: World
Health Organization. WEB ANNEX D.
Maheu-Giroux M (2017). A Bayesian framework for
global, regional, and national estimates of violence against women
statistics. Reported submitted to the World Health Organization, Dept.
of Reproductive Health and Research. 88 pages.
Diabaté S, Maheu-Giroux M, Vesga JF, Boily MC, and
Alary M (2015). Plan d’accélération de la réponse nationale au VIH en
Côte d’Ivoire. Rapport présenté à ONUSIDA – Région d’Afrique de l’ouest
et du centre. 145 pages.
Maheu-Giroux M and Belvisi J (2007). Volet
Biodiversité de l’Initiative Nationale d’Élaboration de Normes
Agroenvironnementales - Démarche d’appui au développement de normes
appliquées au projet pilote de l’écorégion des basses-terres du
Saint-Laurent. Rapport présenté à Environnement Canada – INÉNA. 245
pages.
Maheu-Giroux M, de Blois S, and Jobin B (2006).
Suivi des habitats et des pressions anthropiques de quatre Réserves
nationales de faune du Québec et leur périphérie à l’échelle du paysage.
Environnement Canada, Service canadien de la faune, Région du Québec. 63
p. + annexes.
Maheu-Giroux M, Boivin P, Brisson J, de Blois S, and
Bouchard A (2003). Évaluation de la résistance de différents mélanges
d’espèces végétales à l’envahissement d’espèces arborescentes >
Protocole expérimental. Institut de Recherche en Biologie Végétale -
Université de Montréal. 25 pages.